Medpace Holdings, Inc. Finite-Lived Intangible Assets, Accumulated Amortization
Medpace Holdings, Inc. (MEDP) had Finite-Lived Intangible Assets, Accumulated Amortization of -$135.34 million as of 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2022-02-15
- 2021-12-31: Finite-Lived Intangible Assets, Accumulated Amortization -$135.34M.
- 2020-12-31: Finite-Lived Intangible Assets, Accumulated Amortization -$130.22M; Finite-Lived Intangible Assets, Accumulated Amortization as first filed $133.30M.
- 2020-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $131.35M.
- 2020-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $129.40M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2021-12-31 | -$135.34M 10-K · filed 2022-02-15 | |
| 2020-12-31 | -$130.22M 10-K · filed 2022-02-15 | $133.30M 10-K · filed 2021-02-16 |
| 2020-09-30 | $131.35M 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $129.40M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $127.42M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $125.42M 10-K · filed 2021-02-16 | $179.90M 10-K · filed 2020-02-25 |
| 2019-09-30 | $249.53M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $246.54M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $243.54M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $165.07M 10-K · filed 2020-02-25 | $237.70M 10-K · filed 2019-02-26 |
| 2018-09-30 | $230.31M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $222.92M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $215.53M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $208.14M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $198.64M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $189.15M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $179.68M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $170.24M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $157.57M 10-Q · filed 2016-11-03 | |
| 2015-12-31 | $119.56M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |